文献速递中毒与环境急症消化、代谢与肾脏急症

阿片类药物使用障碍在急诊科的临床表现与治疗差异:一项混合方法研究

Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study.
PubMed 文献 · Am J Emerg Med · 2023-01-07
一句话结论急诊阿片类药物使用障碍治疗依临床表现差异显著:过量就诊接受MOUD仅6%,戒断就诊达69%。

该混合方法研究分析了2018年12月至2020年7月三家城市学术急诊科1339次阿片相关就诊,评估不同临床表现(过量、戒断、其他)下接受阿片类药物使用障碍药物治疗(MOUD)的差异,并结合2020年1月至4月28名急诊医护的5个焦点小组讨论。结果显示23%的患者在就诊期间或出院时接受MOUD;过量表现治疗率最低(6%),戒断表现最高(69%,p<0.001);出院时丁丙诺啡处方率15%,戒断、其他、过量分别为42%、14%、5%(p<0.001)。焦点小组强调患者接受度、医生信心和临床准备度是成功启动治疗的关键。

要点

  • 在1339次阿片相关就诊中,23%的患者在就诊期间或出院时接受了MOUD。
  • MOUD治疗率因临床表现而异:过量就诊仅6%,戒断就诊69%(p<0.001)。
  • 出院时丁丙诺啡处方率为15%,戒断就诊42%、其他OUD相关就诊14%、过量就诊5%(p<0.001)。
  • 焦点小组中医护强调患者感知接受度、医生信心和患者临床准备度是成功启动治疗的关键方面。
  • 作者认为需要针对性临床指导以改善当前实践。

适用人群与场景

  • 三家城市学术急诊科中阿片类药物使用障碍相关就诊患者,就诊时间2018年12月至2020年7月。
  • 临床表现分为过量、戒断和其他OUD相关状况。

研究设计与关键结果

  • 研究类型为混合方法研究,分析三家城市学术急诊科1339次阿片相关就诊的治疗结局,并整合5个焦点小组(28名急诊医生和护士,2020年1月至4月)的结果。
  • 1339次就诊中,过量265次(20%)、戒断123次(9%)、其他OUD相关状况951次(71%)。
  • 23%的患者在就诊期间或出院时接受MOUD;过量表现治疗率最低(6%),戒断表现最高(69%,p<0.001)。
  • 出院时丁丙诺啡处方率15%,其中戒断就诊42%、其他OUD相关就诊14%、过量就诊5%(p<0.001)。
  • 焦点小组中,医护强调OUD患者急诊表现存在差异,并指出成功启动治疗的关键方面包括感知的患者接受度、医生信心和患者临床准备度。

证据类型、等级与局限

  • 证据类型:混合方法研究(定量治疗结局分析结合焦点小组定性研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,急诊OUD治疗因临床表现而异,焦点小组确定了若干可通过针对性指导或新方法改善当前实践的领域。
  • 作者认为,这些结果凸显了量身定制临床指导的必要性,并可为旨在增加急诊启动OUD治疗的卫生系统和政策干预提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is strong evidence for emergency department (ED)-initiated treatment of opioid use disorder (OUD). However, implementation is variable, and ED management of OUD may differ by clinical presentation. Our aim was to use mixed methods to explore variation in ED-based OUD care by patient clinical presentation and understand barriers and facilitators to ED implementation of OUD treatment across scenarios.

METHODS: We analyzed treatment outcomes in OUD-related visits within three urban, academic EDs from 12/2018 to 7/2020 following the implementation of interventions to increase ED-initiated OUD treatment. We assessed differences in treatment with medications for OUD (MOUDs) by clinical presentation (overdose, withdrawal, others). These data were integrated with results from 5 focus groups conducted with 28 ED physicians and nurses January to April 2020 to provide a richer understanding of clinician perspectives on caring for ED patients with OUD.

RESULTS: Of the 1339 total opioid-related visits, there were 265 (20%) visits for overdose, 123 (9%) for withdrawal, and 951 (71%) for other OUD-related conditions. 23% of patients received MOUDs during their visit or at discharge. Treatment with MOUDs was least common in overdose presentations (6%) and most common in withdrawal presentations (69%, p < 0.001). Buprenorphine was prescribed at discharge in 15% of visits, including 42% of withdrawal visits, 14% of other OUD-related visits, and 5% of overdose visits (p < 0.001). In focus groups, clinicians highlighted variation in ED presentations among patients with OUD. Clinicians also highlighted key aspects necessary for successful treatment initiation including perceived patient receptivity, provider confidence, and patient clinical readiness.

CONCLUSIONS: ED-based treatment of OUD differed by clinical presentation. Clinician focus groups identified several areas where targeted guidance or novel approaches may improve current practices. These results highlight the need for tailored clinical guidance and can inform health system and policy interventions seeking to increase ED-initiated treatment for OUD.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Faude S, Delgado MK, Perrone J, et al. Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study. Am J Emerg Med. 2023. PMID: 36706482. doi:10.1016/j.ajem.2023.01.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。